Categories AlphaGraphs, Cannabis, Earnings

Earnings: A Snapshot of Hexo’s Q1 2023 financial results

Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a narrower net loss for the first quarter of 2023 amid a sharp fall in operating expenses. The Canada-based company’s revenues decreased in double-digits during the three-month period.

Net loss and comprehensive loss narrowed sharply to C$52.1 million in the October quarter from C$116.9 million in the prior-year period.

At C$35.77 million, net revenues were down 29% year-over-year, reflecting lower sales across all the main operating segments. Total operating expenses declined 81% year-over-year.


Check this space to read management/analysts’ comments on quarterly reports


“We’ve increased our gross profit before fair value adjustments by approximately $41 million over the previous quarter and have significantly decreased our inventory levels. We’ve also eliminated unprofitable sales, redeploying those resources into profitable business segments,” said Hexo’s CFO Julius Ivancsits.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment. These factors have put pressure on the drugstore

Main points from Accenture’s (ACN) Q3 2024 earnings report

Shares of Accenture (NYSE: ACN) rose 6% on Thursday, following the company’s announcement of its third-quarter 2024 earnings results. Although revenue and profits missed expectations, the stock jumped after the

ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues

Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter. The Canada-based recreational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top